Hereditary Breast And Ovarian Cancer Syndrome (BRCA1/2)

Inherited mutations in the BRCA1 and BRCA2 genes cause the hereditary breast and ovarian cancer (HBOC) syndrome. Usually helping to repair damaged DNA, these genes greatly raise a person's lifelong chance of getting breast, ovarian, prostate, and pancreatic cancers when they are mutant. Women having BRCA mutations run up to a 72% lifetime risk of breast cancer and up to 44% for ovarian cancer.
A mutation from one parent causes HBOC, an autosomal dominant form that increases cancer risk. HBOC syndrome may be suggested by a family history of early-onset breast cancer, bilateral breast cancer, male breast cancer, or many related cancers.
By verifying BRCA mutations, genetic testing enables preventive treatments, including chemoprevention, risk-reducing operations like salpingo-oophorectomy or mastectomy, and improved screening. Targeted treatments for BRCA-related malignancies have shown potential with PARP inhibitors.
Early identification through genetic counselling helps people and families make wise decisions regarding their health, thereby enhancing results and maybe saving lives.